Open-Label Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-Steroidal Anti-Inflammatory Drug Treatment.
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2014
At a glance
- Drugs Ibuprofen/famotidine (Primary)
- Indications Back pain; NSAID-induced gastrointestinal damage; Osteoarthritis; Pain; Rheumatoid arthritis
- Focus Adverse reactions; Registrational
- Sponsors Horizon Pharma
- 24 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2010 Planned end date changed from 1 Mar 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.
- 16 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.